Exploring MicroRNA and Exosome Involvement in Malignant Pleural Mesothelioma Drug Response

SIMPLE SUMMARY: Malignant pleural mesothelioma (MPM) is a deadly thoracic malignancy with limited treatment options. Chemotherapy remains the most widely used first-line treatment for unresectable MPM but is hampered by drug resistance issues. Small molecule inhibitors and microRNA mimics have shown...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Ben, Zhuang, Ling, Rath, Emma M., Yuen, Man Lee, Cheng, Ngan Ching, Shi, Huaikai, Kao, Steven, Reid, Glen, Cheng, Yuen Yee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564288/
https://www.ncbi.nlm.nih.gov/pubmed/36230710
http://dx.doi.org/10.3390/cancers14194784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564288/
https://www.ncbi.nlm.nih.gov/pubmed/36230710
http://dx.doi.org/10.3390/cancers14194784

Ejemplares similares